Blog Posts

BIG PHARMA WATCH: STUDY FINDS DRUG COMPANIES HIKED PRICES FASTER THAN INFLATION ON 23 OF TOP 25 MOST POPULAR MEDICARE PART D DRUGS

Feb 28, 2022

KFF Analysis Shows Big Pharma’s Price Hikes Outpaced Inflation for Half of Read More

BIG PHARMA EARNINGS WATCH: MERCK, ELI LILLY, AMGEN, PFIZER, GLAXOSMITHKLINE, ASTRAZENECA

Feb 18, 2022

New Earnings Reports Show Big Pharma Giants Continue to Reap Massive Profits, Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, SANOFI, BRISTOL-MYERS SQUIBB, NOVARTIS

Feb 11, 2022

New Q4 Earnings Reports Underscore How Big Pharma’s Pandemic Price Hikes, Read More

SECOND OPINION: PHRMA STUDY REHASHES DEBUNKED SUPPLY CHAIN BLAME GAMES

Feb 3, 2022

Big Pharma Sidesteps Industry’s Own Price Hikes and Egregious Practices in Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jan 28, 2022

J&J Surpasses Wall Street Expectations, Nearly Tripling Year-Over-Year Read More

DOSE OF REALITY: NEW ANALYSIS UNDERSCORES HOW OFTEN BIG PHARMA’S PATENTS ARE UNRELATED TO CLINICAL INNOVATION

Jan 19, 2022

Study Finds Just Six Percent of Drug Patents in Infringement Suits Were for Read More

SECOND OPINION: BIG PHARMA CEO CLAIMS “COURAGEOUS” TO PRICE UNPROVEN TREATMENT 10 TIMES ESTIMATE OF FAIR PRICE

Jan 11, 2022

Biogen Decision to Change Aduhelm Price After Public Outcry Demonstrates Big Read More

BIG PHARMA WATCH: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 588

Jan 7, 2022

Brand Name Drug Companies’ Business-as-Usual Approach to Price Increases Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART I

Dec 28, 2021

Part I: Price-Gouging An Unproven Treatment, Setting Out-of-Control Launch Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART II

Dec 28, 2021

Part II: Pushing Debunked Innovation Rhetoric to Oppose Rx Solutions Despite Read More

DOSE OF REALITY: BIG PHARMA’S YEAR OF BAD BEHAVIOR — PART III

Dec 28, 2021

Part III: Big Pharma Maintains Price-Hiking, Patent-Gaming Business-As-Usual Read More

DOSE OF REALITY: OVERSIGHT REPORT EXPOSES BIG PHARMA’S EGREGIOUS PRICING & ANTI-COMPETITIVE TACTICS — DEBUNKS INNOVATION RHETORIC

Dec 12, 2021

Investigation Finds Big Pharma Hiked Prices More Than 250 Times On Just 12 Top Read More